E Berezovsky

Dr. Elizabeth Hulme Berezovsky is a Harvard-trained R&D leader with a passion for transforming innovative discoveries into treatments and cures for human disease.  Most recently, she was Director of Technical Operations at BioMotiv, a mission-driven drug development accelerator in Cleveland, Ohio, where she oversaw R&D operations for BioMotiv’s portfolio of drug development start-ups.  She directed development at two BioMotiv subsidiary companies: Allinaire Therapeutics, an early-stage company developing treatment for COPD and other pulmonary diseases; and SapVax, a cancer vaccine platform company.

Dr. Berezovsky was an NIH Ruth L. Kirschstein NRSA Post-Doctoral Fellow at the Cleveland Clinic in the Department of Molecular Genetics.  She received her Ph.D. in chemistry under the direction of Professor George M. Whitesides at Harvard University, and holds an undergraduate degree in chemistry from McGill University.


Research Executive for start-ups


Strategic Planning & Execution

Virtual R&D Management



Opportunity Evaluation for licensees/investors

Holistic Assessment

Technology Review

Commercial Evaluation



Portfolio strategy For institutions 

Portolio Prioritization 

Intellectual Property Strategy

Technology Advisory Services



get in touch